Dxevo is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Phlight Pharma, Llc. The primary component is Dexamethasone.
Product ID | 70569-151_8baea07b-6071-3742-e053-2a95a90acd82 |
NDC | 70569-151 |
Product Type | Human Prescription Drug |
Proprietary Name | Dxevo |
Generic Name | Dexamethasone |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-06-17 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA201270 |
Labeler Name | Phlight Pharma, LLC |
Substance Name | DEXAMETHASONE |
Active Ingredient Strength | 2 mg/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-06-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA201270 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-06-17 |
Ingredient | Strength |
---|---|
DEXAMETHASONE | 1.5 mg/1 |
SPL SET ID: | e362f596-dad7-4793-a6e6-bf05a742f449 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
70362-707 | Dxevo | Dxevo |
70362-702 | Dxevo | Dxevo |
70569-151 | Dxevo | Dxevo |
0054-3177 | Dexamethasone | Dexamethasone |
0054-4179 | Dexamethasone | Dexamethasone |
0054-4180 | Dexamethasone | Dexamethasone |
0054-4181 | Dexamethasone | Dexamethasone |
0054-4182 | Dexamethasone | Dexamethasone |
0054-4183 | Dexamethasone | Dexamethasone |
0054-4184 | Dexamethasone | Dexamethasone |
0054-4186 | Dexamethasone | Dexamethasone |
0054-8174 | Dexamethasone | Dexamethasone |
0023-3348 | OZURDEX | dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DXEVO 88334412 not registered Live/Pending |
LARKEN LABORATORIES, INC. 2019-03-11 |
DXEVO 88245240 not registered Live/Pending |
Innovate Research & Development, LLC 2018-12-29 |